First biotech IPO on NASDAQ in 2024. Exciting times! https://lnkd.in/gv4GNQDu
CG Oncology is ringing in its next chapter and listing on Nasdaq! 🛎️🧬 At the intersection of science and patient care, $CGON is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Congratulations to the entire CG Oncology team on this milestone. 🎉